BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Bifidobacterium |
📓
Lactobacillus rhamnosus TR08 Improves Dyslipidemia in Mice Fed with a High Fat Diet by Regulating the Intestinal Microbiota, Reducing Systemic Inflammatory Response, and Promoting Sphingomholipid Metabolism. Molecules (Basel, Switzerland) (Molecules ) Vol: 27 Issue 21 Pages: Pub: 2022 Oct 29 Epub: 2022 Oct 29 Authors Feng X , Ding L , Ma G , Zhang Y , Sun Y , Li Z , Tao X , Ali A , Wang D , Wu L , Html Article Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Bifidobacterium |
👪
Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota. Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 772532 Pub: 2021 Epub: 2021 Dec 14 Authors Gao G , Ma T , Zhang T , Jin H , Li Y , Kwok LY , Zhang H , Sun Z , Html Article Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Bifidobacterium |
📓
Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. Food & function (Food Funct ) Vol: 12 Issue 11 Pages: 5171-5186 Pub: 2021 Jun 8 Epub: Authors Pang B , Jin H , Liao N , Li J , Jiang C , Shao D , Shi J , Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Bifidobacterium |
📓
Multi-Strain Probiotics Alleviate Alcoholic Liver Disease Via Microbiota-Metabolism Axis: A Randomized Controlled Study. Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2025 Nov 3 Epub: 2025 Nov 3 Authors Feng J , Wu J , Zhang M , Chen W , Zhao J , Lv Y , Lai R , Fang S , Li Y , Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Bifidobacterium |
📓
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model. Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 222 Issue Pt 2 Pages: 117757 Pub: 2025 Dec Epub: 2025 Oct 31 Authors Vaccalluzzo A , Celano G , Calabrese FM , Pino A , Caggia C , De Angelis M , Randazzo CL , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
